Sangamo Biosciences (SGMO) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
Research grants: 95K
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: -5.7%
Financial Fact:
Research grants: 95K
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Sangamo Biosciences (NASDAQ: SGMO) reported Q3 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $8.27 million.
Sangamo Biosciences sees FY2014 revenue of $45-50 million, versus the consensus of $47.57 million.
For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Doximity downgraded by BofA on AI investment concerns, margin pressure
- Bernstein SocGen on UnitedHealth Group (UNH): 'Expecting a strong 2Q driven by MA and potential for guidance raise'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
